🔴 Rocket Pharmaceuticals is trading 5.16% down today with no fresh company-specific catalyst identified

Rocket Pharmaceuticals is trading 5.16% down at $3.58, with no new company-specific announcement identified for August 26, 2026.

• Latest listed releases cover second-quarter results and earlier Danon disease safety updates, not a fresh session catalyst.
• The decline follows a 7.08% gain on August 25.
• Broader U.S. markets are only modestly lower, leaving the immediate cause uncertain.